Cholesterol Testing Services Market

The global cholesterol testing services market is expected to reach USD 17.57 Billion by 2021 from an estimated value of USD 11.96 Billion in 2016, growing at a CAGR of 8% during the forecast period.

According to the new market research report “Cholesterol Screening/ Cholesterol Lab Testing Services Market by Type of Customer (Physician/Provider, Hospital, Employer, Health Plan, MCO, Government, ACO, IDN, Patient), Geography (North America, Europe) & Qualitative Assessment – Forecasts to 2021”, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

Don’t miss out on business opportunities in Cholesterol Screening/ Cholesterol Lab Testing Services Market. Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=180941049

Factors such as increasing incidence of cardiovascular diseases and obesity, physician preference of laboratory testing rather self-testing, growing awareness and adoption of preventive healthcare, government initiatives to improve the quality of testing, and rapid growth in the geriatric population are propelling the growth of this market. Moreover, emerging economies offer significant growth opportunities for players operating in the cholesterol testing services market. On the other hand, rapidly growing home/self-testing and emergence of non-invasive cholesterol testing methods are the major factors that may limit growth of the market to a certain extent.

The cholesterol testing services market is segmented based on type of customer and region. Based on type of customer, the market is segmented into physicians/providers and hospitals; employers, health plans, and Managed Care Organizations (MCOs); government agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs); and patients. The patient-driven cholesterol testing segment is expected to grow at the highest CAGR during the forecast period, mainly due to increasing awareness and adoption of preventive healthcare, availability of lab test services for patients without any physician intervention thus reducing the waiting time to get appointment from physicians, and online access to reports and readings through smartphones.

 Browse and in-depth TOC on “ Cholesterol Testing Services Market

33 – Tables

21 – Figures

139 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/cholesterol-testing-services-market-180941049.html

The market for cholesterol testing services is expected to register significant growth in the coming years with the increasing incidence of cardiovascular diseases and obesity, physician preference for lab testing over self-testing, growing awareness and adoption of preventive healthcare, government initiatives to improve the quality of testing, and rapid growth in the geriatric population. On the other hand, the rapidly growing home/self-testing market and emergence of noninvasive cholesterol testing methods are expected to restrain the growth of this cholesterol testing market to a certain extent.

The report categorizes the cholesterol testing market on the basis of type of customer and region. Based on type of customer, the market is segmented into physicians/providers and hospitals; employers, health plans, and Managed Care Organizations (MCOs); government agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs); and patients. In 2016, the physicians/providers and hospitals segment is projected to account for the largest share of the market. The large share of this segment can be attributed to factors such as dependence of physicians on cholesterol test results for making CVD risk assessments and treatment decisions and reimbursement of tests that are prescribed by physicians/doctors.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=180941049

The cholesterol testing market is segmented on the basis type of customer and region. Based on type of customer, the market is segmented into physicians/providers and hospitals; employers, health plans, and Managed Care Organizations (MCOs); government agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs); and patients. Companies in the market are coming up with innovative offerings to provide accurate and up-to-date diagnostic information to their customers. In November 2016, Quest Diagnostics (U.S.) launched the QuestDirect, a new patient-initiated testing service, in the U.S. This new service will allow the customers better manage their health by ordering certain lab tests directly without any physician intervention.

Based on region, the cholesterol testing services market is segmented into North America, Europe, Asia, and RoW. North America is expected to dominate the global cholesterol testing market in 2016, with the U.S. accounting for a major share. Asia is projected to be the fastest-growing region in terms of CAGR during the forecast period. This is due to the large population base, increased prevalence of cardiovascular diseases, and growing number of testing facilities in the Asian region.

Major players in the cholesterol testing market include Laboratory Corporation of America Holdings (LabCorp) (U.S.), Quest Diagnostics Incorporated (U.S.), Eurofins Scientific (Luxembourg), Spectra Laboratories Inc. (U.S.), Unilabs (Switzerland), SYNLAB International GmbH (Germany), Bio-Reference Laboratories Inc. (U.S.), Clinical Reference Laboratory, Inc. (CRL) (U.S.), ACM Medical Laboratory (U.S.), and Adicon Clinical Laboratory (China).


Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Contact Us:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cholesterol-testing-services-market.asp

Visit Our Website: https://www.marketsandmarkets.com



Reset Password